Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 10, 2023
Patent Application Number
16684271
Date Filed
November 14, 2019
Patent Primary Examiner
CPC Code
The present embodiments provide methods, compounds, and compositions useful for inhibiting FOXP3 expression, which may be useful for treating, preventing, or ameliorating cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
